| COVID-19 Vaccine |
1 |
0.7 |
| Child |
0 |
1 |
| Otolaryngology |
0 |
0.45 |
| Vaccines |
0 |
0.41 |
| Food and Drug Administration (FDA) |
0 |
0.4 |
| Patient Safety |
0 |
0.34 |
| Myocarditis |
0 |
0.24 |
| Cardiomyopathy |
0 |
0.22 |
| COVID-19 |
0 |
0.19 |
| Pandemic |
0 |
0.1 |
| Adverse Effects |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Immunization |
0 |
0.07 |
| Arthralgia |
0 |
0.05 |
| Centers for Disease Control and Prevention |
0 |
0.03 |
| Cough |
0 |
0.03 |
| Fatigue |
0 |
0.03 |
| Headache |
0 |
0.03 |
| Insomnia |
0 |
0.03 |
| Isolation |
0 |
0.03 |
| Medical Innovations |
0 |
0.03 |
| Michigan |
0 |
0.03 |
| Muscle |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.03 |
| Sleep Disorders |
0 |
0.03 |
| Travel Medicine |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |